Rising popularity of Novo Nordisk’s Ozempic is making it more difficult to find, leaving some patients to turn to unauthorized alternatives, The New York Times reported May 16.
Read the full post on Becker's Hospital Review - Healthcare News
Ozempic alternatives concern health experts
